ISHEID
     
WEDNESDAY, MAY 16, 2018
   

To view the video of the session, click on this icon.

     
09 45
10.00

WELCOME ADDRESS

CALLELONGUE: Alain LAFEUILLADE, Sainte Musse Hospital, Toulon - France
Christina PSOMAS, Montpellier - France
   
10.00
10.30

INTRODUCTION KEYNOTE LECTURE

CALLELONGUE: Chairs: Sabine KINLOCH, Royal Free Hospital, London - England
Jean-Pierre ROUTY, McGill University, Montreal - Canada
Presentation

From HIV to global health
Stefano VELLA, Superior Health Institute, Rome - Italy

     
10.30
11.00

KEYNOTE LECTURE

CALLELONGUE: Chairs: Marie-Lise GOUGEON, Pasteur Institute, Paris - France
Jean-Pierre ROUTY, McGill University, Montreal - Canada
Presentation

TLR7 agonists for the treatment of HIV
Romas GELEZIUNAS, Gilead Sciences, Foster City - USA

     
11.30
13.00

WHAT’S UP IN HIV?

Under the auspices of GILEAD
CALLELONGUE: Chairs: Sabine KINLOCH, Royal Free Hospital, London - England
Christina PSOMAS, Montpellier - France
Presentation

Therapeutic vaccines: is HIV eradication possible?
Beatriz MOTHE PUJADAS, Hospital Germans Trias i Pujol, Barcelona - Spain

Presentation

Total HIV DNA threshold as guidance for simplification strategies
Sofie RUTSAERT, Gent University, Gent - Belgium

Presentation

Shall we switch anyone to bitherapy?
Chloe ORKIN, Barts Health NHS Trust, London - England

     
11.30
13.00

EMERGING INFECTIOUS DISEASES

MORGIOU: Chairs: Jean-Pierre ROUTY, McGill University, Montreal - Canada
Hervé TISSOT-DUPONT, Conception Hospital, Marseille - France
Presentation

A Platform for the Integrated Control of Arbovirosis in CATalonia (PICAT): Mosquito Alert 2.0
Frederic BARTUMEUS, Blanes advanced study center, Girona - Spain

Presentation

Climate change, socio-political changes and emerging pandemics
Jean-Paul GONZALEZ, Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Manhattan, Kansas - USA

Presentation

O1. Detection of emerging avian influenza A H7N9 virus based on a rapid and sensitive intensity-modulated SPR biosensor
Authors: Sheng-Fan WANG (1), Wen-Hung WANG (2), Ying-Feng CHANG (3), Ruei-Yu YUAN (1), Yi-Wei HONG (1), Li-Chen SU (4)

(1) Kaohsiung Medical University, Department of Medical Laboratory Science and Biotechnology, Kaohsiung - Taiwan
(2) Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Division of Internal Medicine, Kaohsiung - Taiwan
(3) National Taiwan University, Department of Biochemical Science and Technology, Bio-Analytical Chemistry and Nanobiomedicine Laboratory, Taipei - Taiwan
(4) Chinese Culture University, Department of Optoelectric Physics, Taipei - Taiwan

 

O2. Risk factors for multidrug-resistant tuberculosis patients in Casablanca-Settat, Morocco, 2012-2016
Author: Soad REDWANE

Ministry, Casablanca - Morocco

     
14.00
15.30

WHAT ABOUT HEPATITIS CURE?

CALLELONGUE: Chairs: Philippe HALFON, European Hospital, Marseille - France
Vicente SORIANO, Hospital Carlos III, Madrid - Spain
Presentation

New antivirals for Hepatitis B
Vicente SORIANO, Hospital Carlos III, Madrid - Spain

Presentation

The emerging of NASH issues after cure of Hepatitis C
Lawrence SERFATY, Hautepierre Hospital, Strasbourg - France

Presentation

O3. Prevalence and incidence of Hepatitis delta in chronic Hepatitis B patients in Spain
Authors: Antonio AGUILERA (1), Vicente SORIANO (2), Rocio TRASTOY (1), Javier RODRIGUEZ-CALVIÑO (1),
Tamara MANSO (1), Carmen De MENDOZA (3)

(1) CHUS, Santiago - Spain
(2) La Paz University Hospital, Madrid - Spain
(3) Puerta de Hierro University Hospital, Madrid - Spain

Presentation

O4. Sero-epidemiological study of adherence to vaccine and humoral response against Hepatitis A virus in HIV-1 patients
Authors: Olga TSACHOURIDOU (1), Marianthi PAPAGIANNI (1), Dimitrios PILALAS (1), Christiana GOGOU (1), Theofilos CHRYSANTHIDIS (1), Dimitrios CHATZIDIMITRIOU (2), Lemonia SKOURA (3), Georgios GERMANIDIS (4), Pantelis ZEMPEKAKIS (5), Symeon METALLIDIS (5)

(1) AHEPA University Hospital Thessaloniki Greece, 1st Internal Medicine Department, Infectious Diseases Unit, Thessaloniki - Greece
(2) AIDS National Reference Centre of Northern Greece, Thessaloniki - Greece
(3) AHEPA University Hospital, Microbiology Department, Thessaloniki - Greece
(4) AHEPA University Hospital, Gastroenterology and Hepatology Department, Thessaloniki - Greece
(5) 1st Internal Medicine Department, Infectious Diseases Unit, Thessaloniki - Greece

 

O5. Incidence and clinical characteristics of acute Hepatitis A in a tertiary referral hospital in Madrid (2008-2017)
Authors: Alberto DÍAZ-DE SANTIAGO, Patricia A. MILLS, Jorge ANEL, Ignacio MORRÁS, Renato CROZZOLI, Victor MORENO-TORRES, Francisca PORTERO, Sara De LA FUENTE, Natalia VICENTE, Alfonso ÁNGEL-MORENO

Puerta de Hierro University Hospital, Madrid - Spain

     
16.00
17.00

CHEM SEX - In partnership with the European AIDS Clinical Society (EACS)

CALLELONGUE: Chairs: Mark NELSON, Chelsea and Westminster Hospital, London - England
Caroline SOLAS, La Timone Hospital, Marseille - France
Presentation

Dominic ROWLEY, Saint James Hospital, Dublin - Ireland

Presentation

Viken DARAKJIAN, Positive People Armenian Network (PPAN) and European AIDS Treatment Group (EATG), Yerevan - Armenia

 

O6. Chemsex on PrEP: risk behaviours and STI incidence among PrEP patients using illicit substances
Authors: Zoë GREENWALD, Mariève BEAUCHEMIN, Danièle LONGPRÉ, Khadija BENOMAR, Stéphane LAVOIE, Réjean THOMAS

L’Actuel Medical Clinic, Montreal - Canada

     
INDUSTRY-SPONSORED SYMPOSIA - DAY BY DAY
     
17.00
18.00

2018: IS IT TIME TO CHANGE THE ESTABLISHED PARADIGMS?

CALLELONGUE:

INDUSTRY-SPONSORED SYMPOSIUM BY MSD

HIV Therapy: is three the Magic number?
Christine KATLAMA, Pitié Salpêtrière Hospital, Paris - France

 

INSTIs in first line: are they all equal for patients?
Mark NELSON, Chelsea and Westminster Hospital, London - England

 

Is an STR the best option for all?
Pierre-Marie GIRARD, Saint Antoine University Hospital, Paris - France

     
     
THURSDAY, MAY 17, 2018
   

To view the video of the session, click on this icon.

     
09.00
10.00

ORAL COMMUNICATIONS

MORGIOU: Chairs: Patrick MALLON, UCD School of Medicine, Dublin - Ireland
Ferdinand WIT, Academic Medical Center, Amsterdam - The Netherlands
Presentation

O7. HIV-1 sequences with more predicted glycans in acute infection were associated with the development of higher neutralization breadth
Authors: Mélanie MERBAH (1), Eric SANDERS-BUELL (1), Gina DONOFRIO (1), Yifan LI (1), Meera BOSE (1), Anne-Marie O’SULLIVAN (1), Samantha TOWNSLEY (1), Bonnie SLIKE (1), Hannah KIBUUKA (2), Lucas MAGANGA (3), Sorachai NITAYAPHAN (4), Leigh-Ann ELLER (1), Shelly KREBS (1), Sodsay TOVANABUTRA (1), Nelson MICHAEL (5), Merlin ROBB (1), Morgane ROLLAND (1)

(1) U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Henry M. Jackson Foundation
for the Advancement of Military Medicine, Silver Spring, Md - USA
(2) Makerere University Walter Reed Project, Kampala - Uganda
(3) Mbeya Medical Research Center, Mbeya - Tanzania
(4) AFRIMS, Bangkok - Thailand
(5) U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Md - USA

 

O8. Frequent CXCR4-tropism in newly diagnosed individuals from an HIV-1 F1 subtype cluster rapidly expanding among men who have sex with men in Spain
Authors: Miguel THOMSON, Elena DELGADO, Vanessa MONTERO, Sonia BENITO, Maria-Terasa CUEVAS, Monica SANCHEZ, Cristina CARRERA, Lucia PEREZ-ÁLVARE
Z
Carlos III Health Institute, National Center of Microbiology, Majadahonda, Madrid - Spain

Presentation

O9. High incidence of sexually transmitted infections in HIV negative MSM patients: a real-life prospective cohort study
Authors: Patrick PHILIBERT (1), Guillaume PENARANDA (2), Laurent CHICHE (1), Stanislas REBAUDET (1), Claire CAMUS (2), Hacène KHIRI (2), Marion DELORD (1), Julie ALLEMAND-SOURRIEU (1), Philippe HALFON (1,2)

(1) European Hospital, Marseille - France
(2) Alphabio Laboratory, Marseille - France

 

10. Fungal microbial translocation changes during treated acute and chronic HIV infection
Authors: Vikram MEHRAJ (1), Rayoun RAMENDRA (1), Cecilia COSTINIUK (2), Bertrand LEBOUCHÉ (2), Rosalie PONTE (1), Réjean THOMAS (3), Jason SZABO (4), Pierre COTÉ (4), Roger LEBLANC (5), Jean-Guy BARIL (4), Cécile TREMBLAY (6), Nicole BERNARD (1), Donald C. SHEPPARD (7), Jean-Pierre ROUTY (8)

(1) Research Institute of McGill University Health Center, Montreal - Canada
(2) McGill University Health Center, Chronic Viral Illness Service, Montreal - Canada
(3) L’Actuel Medical Clinic, Montreal - Canada
(4) Quartier Latin Medical Clinic, Montreal - Canada
(5) OPUS Medical Clinic, Montreal - Canada
(6) Montreal University Hospital Research Center, Montreal - Canada
(7) McGill University, Department of Microbiology and Immunology, Montreal - Canada
(8) McGill University, Montreal - Canada

Presentation

11. Two diseases, same person: moving towards a combined HIV and TB continuum of care
Authors: Reuben GRANICH (1), Somya GUPTA (2)

(1) Independent Consultant, San Francisco - USA
(2) Independent Consultant, New Delhi - India

     
09.00
10.00

LYME DISEASE

CALLELONGUE: Chairs: Adrian CURRAN, University of Barcelona, Barcelona - Spain
Patricia ENEL, Public Health Department / COREVIH, Marseille - France
Presentation

Diagnosis, treatment and controversy
Christian PERRONNE, Raymond Poincaré Hospital, Garches - France

10.00
11.00

KEYNOTE LECTURE

CALLELONGUE: Chairs: Christina PSOMAS, Montpellier - France
Jean-Pierre ROUTY, McGill University, Montreal - Canada
Presentation

The microbiome
Sergio SERRANO, Ramon y Cajal Hospital, Madrid - Spain

Presentation

O12. Expansion of the enteric virome in untreated HIV infection
Authors: Celia BOUKADIDA, Sandra PINTO-CARDOSO, Ana Paola CARRANCO-ARENAS, Monserrat CHÁVEZ-TORRES, Daniela GARRIDO-RODRÍGUEZ, Amy PERALTA-PRADO, Gustavo REYES-TERÁN

National Institute of Respiratory Diseases, Infectious Diseases Unit, Mexico City - Mexico

     
11.30
13.00

NEW PATHS ON HIV CURE

CALLELONGUE: Chairs: Sabine KINLOCH, Royal Free Hospital, London - England
Jean-Pierre ROUTY, McGill University, Montreal - Canada
Presentation

Shock and kill strategies vs reinforced silencing of latent provirus
Ole Schmeltz SOGAARD, Aarhus University, Aarhus - Denmark

Presentation

What's up in HIV latence and cure?
Christina PSOMAS, Montpellier - France

O13. A combination of broad neutralizing antibodies efficiently protects from in vitro cell-associated SHIV162P3 transmission
Authors: Karunasinee SUPHAPHIPHAT (1), Monica TOLAZZI (2), Céline GOMMET (1), Nathalie BOSQUET (1), Gabriella SCARLATTI (2), Roger LE GRAND (1), Mariangela CAVARELLI (1)

(1) CEA-University Paris Sud-INSERM U1184, Infectious Disease Models for Innovative Therapies (IDMIT), Fontenay-aux-Roses - France
(2) San Raffaele Scientific Institute, Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, Milan - Italy

Presentation

O14. Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect
Authors: Reuben GRANICH (1), Somya GUPTA (2)

(1) Independent Consultant, San Francisco - USA
(2) Independent Consultant, New Delhi - India

Presentation

O15. Rate of HIV rebound and CD4 T cell kinetics in an aging population on successful antiretroviral therapy
Authors: Abhishek KATIYAR (1), Esther GATHOGO (1), Sabine KINLOCH (1), Margaret JOHNSON (1), Fiona LAMPE (2), Colette SMITH (2)

(1) Royal Free Hospital, London - England
(2) University College London, London - England

     

14.30
16.00

THERAPEUTIC MANAGEMENT OF COMORBID DISEASES

CALLELONGUE: Chairs: Jose Ignacio BERNARDINO, La Paz University Hospital, Madrid - Spain
Christina PSOMAS, Montpellier - France
Presentation

Bone disorders
Patrick MALLON, UCD School of Medicine, Dublin - Ireland

Presentation

Dealing with multimorbidities in HIV
Rosan VAN ZOEST, Institute for Global Health and Development, Amsterdam - The Netherlands

Presentation

HIV and lungs at the time of effective ART
Jean-Pierre ROUTY, McGill University, Montreal - Canada

Presentation

O16. Environmental and occupational exposures as predictors of airflow obstruction in an HIV tertiary care clinic
Authors: Cecilia COSTINIUK (1), Roy NITULESCU (1), Zahra SANEEI (1), Natale WASEF (2), Syim SALAHUDDIN (1), Christina De CASTRO (1), Donatella WASEF (1), Bertrand LEBOUCHE (1), Joseph COX (1), Benjamin SMITH (1), Jason SZABO (1), Mohammad-Ali JENABIAN (3), Jean BOURBEAU (4), Marina KLEIN (1)

(1) McGill University Health Center, Chronic Viral Illness Service, Montreal - Canada
(2) National University of Ireland, Galway - Ireland
(3) University of Quebec at Montreal (UQAM), Montreal - Canada
(4) McGill University Health Center, Division of Respirology, Montreal - Canada

Presentation

O17. Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCD ID cohort
Authors: Aoife LACEY (1), Willard TINAGO (1), Nicholas R. POWER (2), Elena ALVAREZ (1), Alan J. MACKEN (1), Gerard SHEEHAN (2), John S. LAMBERT (2), Aoife G. COTTER (3), Patrick W.G. MALLON (1,2)

(1) University College Dublin, School of Medicine, HIV Molecular Research Group, Dublin - Ireland
(2) Mater Misericordiae University Hospital, Infectious Diseases Department, Dublin - Ireland
(3) University College Dublin, School of Medicine, HIV Molecular Research Group, Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin, Ireland

     

16.30
17.30

KEYNOTE LECTURE

CALLELONGUE: Chairs: Valérie MARTINEZ, Pitié Salpétrière Hospital, Paris - France
Christina PSOMAS, Montpellier - France
Presentation

Immunotherapies and immune check-points
Jean-Philippe SPANO, Pitié-Salpêtrière Hospital, Paris - France

17.30
18.30

WORKSHOP ON PREPS

CALLELONGUE: Chairs: Jose Ignacio BERNARDINO, La Paz University Hospital, Madrid - Spain
Adrian CURRAN, University of Barcelona, Barcelona - Spain
 

The decrease of new infections due to early treatment or PrEPs?
Gary WHITLOCK, Chelsea and Westminster Hospital, London - England

 

Generic PrEPs
Andrew HILL, Liverpool University, Liverpool - England

17.30
18.30

WORKSHOP ON STDS

MORGIOU: Chairs: Patricia ENEL, COREVIH, Marseille Hospital, Marseille - France
Patrick PHILIBERT, COREVIH, European Hospital, Marseille - France
Presentation

Changing the face of STDs
Dominique TESSIER, Travel Medicine Clinic, Montreal - Canada

Presentation

HPV vaccination: use in prevention and in cure
Deborah KONOPNICKI, Saint Pierre University Hospital, Brussels - Belgium

     
INDUSTRY-SPONSORED SYMPOSIA - DAY BY DAY
     
13.00
14.30

MASTERING THE ART: DESIGNING A VISION FOR FUTURE HIV TREATMENT

CALLELONGUE:

INDUSTRY-SPONSORED SYMPOSIUM BY GILEAD
Chair: Anne-Geneviève MARCELIN, Pierre et Marie Curie University, Clermont-Ferrand - France

 

Lessons from the history of ART
Jonathan CARTLEDGE, Mortimer Market Center, London - England

 

20:20 - Answering the unknown to shape a vision of treatment
Pierre CORBEAU, Montpellier University, Montpellier - France

 

A virologist’s impression on different treatment strategies
Anne-Geneviève MARCELIN, Pierre et Marie Curie University, Clermont-Ferrand - France

 
     
FRIDAY, MAY 18, 2018
   

To view the video of the session, click on this icon.

     
08.30
09.00

CLINICAL RESEARCH AND METHODOLOGY

CALLELONGUE: Chairs: Jean-Jacques PARIENTI, Caen University Hospital, Caen - France
Caroline SABIN, Royal Free Campus, London - England
Presentation

In silico clinical research, keep it dynamic!
Rodolphe THIEBAUT, Research Center “Bordeaux Population Health” U1219, Bordeaux - France

Presentation

Cohorts
Caroline SABIN, Royal Free Campus, London - England

     
09.30
10.00

KEYNOTE LECTURE

CALLELONGUE: Chairs: Sabine KINLOCH, Royal Free Hospital, London - England
Ferdinand WIT, Academic Medical Center, Amsterdam - The Netherlands
Presentation

How to measure HIV-1 reservoirs and predict outcomes of treatment interruptions?
Alexander PASTERNAK, Academic Medical Center, Amsterdam - The Netherlands

     
09.30
11.00

SESSION COREVIH - LE PARCOURS DE SANTÉ DU PVVIH (in French)

MORGIOU: Modérateurs : Patricia ENEL, Présidente COREVIH Paca Ouest Corse, Marseille - France
Pascal PUGLIESE, Président COREVIH Paca Est, Nice - France
Presentation

Protocole de coopération médecin infirmier dans la prise en charge des PVVIH
Guillaume GRAS, COREVIH Centre Val de Loire, Tours - France

 

Allègement thérapeutique
Roland LANDMAN (Essai Quatuor), Hôpital Bichat, Paris - France

 

Le témoignage du patient
Jean-Daniel MATTHIEU, Réseau Santé Marseille Sud, Marseille - France

     
10.00
11.00

ELECTRONIC TECHNOLOGY TO IMPROVE HIV MANAGEMENT

CALLELONGUE: Chairs: Christina PSOMAS, Montpellier - France
Lene RYOM, Center of Excellence for Health, Immunity and Infections, Copenhagen - Denmark
Presentation

The future of digital games for HIV prevention and care
Lynn FIELLIN, The play2PREVENT Lab at the Yale Center for Health & Learning Games, New Haven - USA

     
11.30
13.00

WHAT’S UP IN PREP - In partnership with the British HIV Association (BHIVA)

CALLELONGUE: Chairs: Chloe ORKIN, Bart Health NHS Trust, London - England
Ferdinand WIT, Academic Medical Center, Amsterdam - The Netherlands
Presentation

PrEP in Europe, where are we?
Rosalind COLEMAN, Joint United Nations Programme on HIV/AIDS, Geneva - Switzerland

Presentation

Cost effectiveness of PrEPs in Europe
Brooke NICHOLS, Johannesburg - South Africa

Presentation

O18. Understanding characteristics of daily and on-demand PrEP prescriptions
Authors: Zoë GREENWALD, Mariève BEAUCHEMIN, Louise CHAREST, Stéphane LAVOIE, Alexandra HAMEL, Danièle LONGPRE, Réjean THOMAS

L’Actuel Medical Clinic, Montreal - Canada

 

O19. High seroconversion rates following PrEP discontinuance in a Montreal clinic
Authors: Zoë GREENWALD, Mariève BEAUCHEMIN, Khadija BENOMAR, Gabrielle LANDRY, Alexandra HAMEL, Michel BOISSONNAULT, Louise CHAREST, Danièle LONGPRE, Stéphane LAVOIE, Réjean THOMAS

L’Actuel Medical Clinic, Montreal - Canada

     
14.30
16.00

THE EXPERT PATIENT

CALLELONGUE: Chairs: Patricia ENEL, Présidente COREVIH Paca Ouest Corse, Marseille - France
Patrick PHILIBERT, European Hospital, Marseille - France
Presentation    

Is research more efficient while involving expert patients? or is it just a political correctness?
Xavier REY-COQUAIS, COREVIH Ile-de-France, Paris - France

From activism to research: the experience of a patient who became expert
Fabienne HEJOAKA, Marseille - France

 

3 commented extracts from the film 120 BPM (Beats per Minute)

     
16.00
16.30

CONGRESS CONCLUSION

CALLELONGUE:

ORAL COMMUNICATION AND POSTER AWARD CEREMONY